Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Retained Earnings (2020 - 2026)

RxSight filings provide 6 years of Retained Earnings readings, the most recent being -$661.0 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 6.26% to -$661.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$661.0 million, a 6.26% decrease, with the full-year FY2025 number at -$661.0 million, down 6.26% from a year prior.
  • Retained Earnings hit -$661.0 million in Q4 2025 for RxSight, down from $60000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $521000.0 in Q3 2024 to a low of -$661.0 million in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$98000.0 (2022), compared with a mean of -$219.9 million.
  • Biggest five-year swings in Retained Earnings: crashed 835268.49% in 2024 and later skyrocketed 128.3% in 2025.
  • RxSight's Retained Earnings stood at -$20000.0 in 2021, then plummeted by 375.0% to -$95000.0 in 2022, then tumbled by 625836.84% to -$594.6 million in 2023, then decreased by 4.62% to -$622.1 million in 2024, then dropped by 6.26% to -$661.0 million in 2025.
  • The last three reported values for Retained Earnings were -$661.0 million (Q4 2025), $60000.0 (Q3 2025), and -$642.1 million (Q2 2025) per Business Quant data.